UPDATE 3-AbbVie's Humira loses momentum, shares plunge

Oct 28 (Reuters) - A slowdown in sales of AbbVie Inc's
Humira arthritis treatment sent the drugmaker's shares
6 percent lower on Friday, highlighting the company's heavy
reliance on the $15...